WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease

Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome measures. The DSM-5 recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for use in neuropsychiatric disorders. The DSM-5 also states proxy measures may be useful when c...

Descripción completa

Detalles Bibliográficos
Autores principales: Downing, Nancy R, Kim, Ji-In, Williams, Janet K, Long, Jeffrey D, Mills, James A, Paulsen, Jane S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350592/
https://www.ncbi.nlm.nih.gov/pubmed/24327189
http://dx.doi.org/10.1038/ejhg.2013.275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350592/
https://www.ncbi.nlm.nih.gov/pubmed/24327189
http://dx.doi.org/10.1038/ejhg.2013.275

Ejemplares similares